Haleon launches £330m share buyback programme
Haleon
391.30p
17:00 31/03/25
Haleon launched a share buyback programme of up to £330m on Friday, representing the remaining portion of the £500m allocated for repurchases in 2025.
FTSE 100
8,582.81
16:59 31/03/25
FTSE 350
4,675.03
16:49 31/03/25
FTSE All-Share
4,623.62
17:14 31/03/25
Pharmaceuticals & Biotechnology
21,522.38
16:49 31/03/25
The FTSE 100 consumer products giant said the initiative followed its £170m off-market share purchase from Pfizer earlier in the month.
It said the first tranche of the buyback would total up to £200m, and will run until no later than 26 June.
Shares repurchased under the tranche would be cancelled, reducing Haleon’s share capital.
The company said it expected the programme to enhance earnings per share, and align it with its broader capital allocation priorities including delivering shareholder returns.
Haleon said it had entered into an irrevocable agreement with Goldman Sachs International to execute the first tranche.
Goldman Sachs would carry out the purchases independently on the London Stock Exchange, including during any closed periods.
Further tranches would be announced in due course.
At 0815 GMT, shares in Haleon were up 0.81% at 385p.
Reporting by Josh White for Sharecast.com.